Get started
Author

Jun‐Shik Choi

Observed names: Choi Jun Shik, Choi Jun-Shik, Jun-Shik Choi, Jun-shik Choi, JunShik Choi, 최준식
Institution: Chosun University
OpenAlex ID: A5113947716
Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
2011 · Jun-Shik Choi, Yong-Ji Piao, et al. · Archives of Pharmacal Research · 211
Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin
2004 · Jun-Shik Choi, Byung-Wok Jo, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 134
Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats
2007 · Xiuguo Li, Jun-Shik Choi · International Journal of Pharmaceutics · 85
Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats
2009 · Sang-Chul Shin, Jun-Shik Choi · Anti-Cancer Drugs · 77
Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits
2005 · Jun-Shik Choi, Xiuguo Li · International Journal of Pharmaceutics · 76
Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol
2003 · Chul Soon Yong, Chae Ha Yang, et al. · International Journal of Pharmaceutics · 75
Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats
2005 · Jun-Shik Choi, Sang-Chul Shin · International Journal of Pharmaceutics · 72
Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone
1998 · Sang-Chul Shin, In-Joon Oh, et al. · International Journal of Pharmaceutics · 67
Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P‐gp inhibition by curcumin
2011 · Chong‐Ki Lee, Sung‐Hwan Ki, et al. · Biopharmaceutics & Drug Disposition · 65
Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: Possible role of cytochrome p450 3A4 and P-glycoprotein inhibition by baicalein
2011 · Cheng Li, Minhee Kim, et al. · Archives of Pharmacal Research · 60
Role of monocarboxylic acid transporters in the cellular uptake of NSAIDs
2005 · Jun-Shik Choi, Ming Ji Jin, et al. · Journal of Pharmacy and Pharmacology · 58
Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats
2009 · Joong‐Hwa Chung, Dong‐Hyun Choi, et al. · Biopharmaceutics & Drug Disposition · 57
Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats
2010 · Chong-Ki Lee, Jun-Shik Choi · Pharmacology · 56
Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats
2009 · Cheng Li, Xiuguo Li, et al. · Archives of Pharmacal Research · 56
Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats
2004 · Jun-Shik Choi, Hoo-Kyun Choi, et al. · International Journal of Pharmaceutics · 54
Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein
2011 · Young-Ah Cho, Jun-Shik Choi, et al. · Pharmacological Reports · 52
Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
2009 · Xiuguo Li, Jun-Shik Choi · PubMed · 51
The effect of verapamil on the pharmacokinetics of paclitaxel in rats
2004 · Jun-Shik Choi, Xiuguo Li · European Journal of Pharmaceutical Sciences · 51
Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin
2010 · Dong-Hyun Choi, Cheng Li, et al. · Journal of Pharmacy and Pharmacology · 50
Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol
2009 · Jun-Shik Choi, Byung-Chul Choi, et al. · Die Pharmazie · 50
PDF
Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil
2008 · Dong-Hyun Choi, Wan-Gyun Shin, et al. · European Journal of Clinical Pharmacology · 44
Effects of morin on the pharmacokinetics of etoposide in rats
2007 · Xiuguo Li, Jae‐Kyung Yun, et al. · Biopharmaceutics & Drug Disposition · 43
Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats
2011 · Cheng Li, Sung-Cil Lim, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 42
Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats
2005 · Jun-Shik Choi, Hyo-Kyung Han · International Journal of Pharmaceutics · 42
The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits
2004 · Jun-Shik Choi, Hyo-Kyug Han · Journal of Pharmacy and Pharmacology · 42
Works count: 157
Citation count: 2,608
H-index: 32
I10-index: 60
Year
Topic
Type